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INTRODUCTION
Fluoride is an effective and safe method for prevention of 
dental caries, and is used for public health intervention in several 
countries through water fluoridation [1]. NaF has been used to 
fluoridate water: as an industry standard for fluoridation and 
as an additive in toothpastes to prevent cavities [2, 3]. It has also 
been used in laundry, metallurgy and organic synthesis of many 
chemicals including fluorocarbons. NaF is also used in medicine 
in some diagnostic procedures employing radiolabeled fluoride. 
Despite its broad usage, in recent years fluoride has raised a 
substantial concerns regarding cellular toxicity in the brain. A 
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Regulation of cell volume is an important aspect of cellular homeostasis during neural activity. This volume regulation is thought to 
be mediated by activation of specific transporters, aquaporin, and volume regulated anion channels (VRAC). In cultured astrocytes, 
it was reported that swelling-induced mitogen-activated protein (MAP) kinase activation is required to open VRAC, which are 
thought to be important in regulatory volume decrease and in the response of CNS to trauma and excitotoxicity. It has been also 
described that sodium fluoride (NaF), a recognized G-protein activator and protein phosphatase inhibitor, leads to a significant 
MAP kinase activation in endothelial cells. However, NaF’s effect in volume regulation in the brain is not known yet. Here, we 
investigated the mechanism of NaF-induced volume change in rat and mouse hippocampal slices using intrinsic optical signal (IOS) 
recording, in which we measured relative changes in intracellular and extracellular volume as changes in light transmittance through 
brain slices. We found that NaF (1~5 mM) application induced a reduction in light transmittance (decreased volume) in CA1 
hippocampus, which was completely reversed by MAP kinase inhibitor U0126 (10 μM). We also observed that NaF-induced volume 
reduction was blocked by anion channel blockers, suggesting that NaF-induced volume reduction could be mediated by VRAC. 
Overall, our results propose a novel molecular mechanism of NaF-induced volume reduction via MAP kinase signaling pathway by 
activation of VRAC.
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recent report from the National Research Council (NRC 2006) in 
US concluded that adverse effects of high fluoride concentrations 
in drinking water might be of concern. Fluoride may cause 
neurotoxicity in laboratory animals with behavioral consequences 
including adverse effects on learning and memory [4-7]. Exposure 
of chronic or sub-chronic dose of fluoride into animal or human 
in developmental stage causes lack of recognition or decrease 
of IQ [8, 9]. Hippocampus has been postulated to be one of the 
target sites attacked by fluoride. Previous reports showed that 
fluorosis might impair hippocampus synaptic interface structure 
[10, 11]. And the changes in the synaptic interface structure would 
necessarily affect the transmission of neural information [12]. A 
recent study reported that fluoride could induce oxidative damage 
in hippocampal neurons in vitro [13]. However, the precise 
molecular mechanism of how fluoride affects hippocampal 
physiology is unknown.
Regulation of cell volume including baseline volume and volume 
dynamics during synaptic activity is an important aspect of cellular 
homeostasis during neural activity [14]. Evoked synaptic activity 
is followed by a rapid shrinkage of the extracellular volume, due to 
swelling of cell volume [15-17]. Cell swelling is substantial, ranging 
from 4 to 30%, depending on various conditions, such as the mode 
of stimulation, type of preparation, and area under investigation 
[18-20]. The volume regulation has a significant impact on the 
concentration of extracellular solutes and ions, and strongly 
influences subsequent neuronal activity [21, 22]. It is thought to 
be mediated by activation of volume regulatory mechanism, such 
as co-transporter and/or anion channels, which are known to be 
dependent on the activation of MAP kinase [10]. For example, 
synaptic stimulation causes release of a number of solutes that 
are removed through a co-transporter, NKCC1, via MAP kinase 
activation [23, 24].
In many biological studies, NaF has been used as an activator 
of the stimulus-response signaling cascade involving mitogen-
activated protein (MAP) kinases, Erk-1 and Erk-2 [25]. Because 
Ras is a direct target of fluoride [26], the Ras/MEKK/MEK-
mediated pathway activates Erk. This provides a useful mechanism 
of NaF-induced Erk activation [23, 26-28]. MAP kinases can 
be activated by growth factors, cytokines, and some G-protein-
coupled receptors, which are involved in the regulation of gene 
expression [29-31]. MAP kinases are also known to regulate 
several ion channel activity; in particular, the VRAC of astrocytes 
was reported to be a cytoplasmic target for the MAP kinase 
signaling pathway [32]. For this reason, the activity of regulatory 
volume system seems to be connected with MAP kinase signaling 
pathway. Therefore, NaF can potentially serve as a useful tool to 
activate VRAC. So far, the effect of NaF in volume regulation in the 
brain has not been determined yet.
In this study, we investigated the involvement of MAP kinase 
in NaF-induced changes of  volume and neural activity in 
hippocampal slices, using IOS recording for volume change for 
neural activity. We utilized U0126, highly selective inhibitor of 
both MEK1 and MEK2 (a type of MAPK/ERK kinase) to inhibit 
MAP kinase. We report that NaF induced a reduction of baseline 
volume and volume dynamics during electrical stimulation, which 
was dependent on the activity of MAP kinase. Furthermore, we 
suggest that VRAC might be responsible for the NaF-induced 
hippocampal volume regulation. 
maTeRIals aND meThODs
Experiments were performed in accordance with National 
Institutes of Health guidelines for animal care and welfare. 
Protocols were approved in advance by the UNC and KIST (Seoul, 
Korea) Institutional Animal Care and Use Committee. Subjects 
were young adult male rats and mice (21~35 days; 50~150 g; 
Sprague-Dawley and C57BL6, Charles River). 
Slice preparation 
Transverse slices of the hippocampus (400 μm thickness) 
were cut using an oscillating tissue slicer (OTS-4000, Electron 
Microscopy Sciences, Vibratome 3000) and placed in a reservoir 
containing ACSF warmed (30oC) and oxygenated (using a 95% 
O2 and 5% CO2 gas mix). Slices remained in the reservoir (never 
less than 1 hr) until transferred by pipette to a submerged position 
in a recording chamber perfused with warmed (28~30.8oC) and 
oxygenated ACSF (perfusion rate 2~3 ml/min). Composition (in 
mM) of the ACSF delivered to the slice prior to treatment with a 
drug or drug combination was 124 NaCl, 3.0 KCl, 2.5 CaCl2, 25 
NaHCO3, 1 MgSO4, 1.25 NaH2PO4, and 10 glucose. After warming 
and oxygenating ACSF was delivered to the submerged slice via 
the chamber perfusion system.
IOS imaging
The slice was transilluminated and images obtained at ×2 or ×4 
magnification using an inverted microscope (Diaphot 200, Nikon) 
and a cooled, slow-scan CCD camera (Photometrics Inc.). An 
intrinsic optical signal (IOS) was evoked within the hippocampi 
by application of a repetitive constant-current stimulus to the 
Schaffer collateral pathway using a glass insulated, 50 μm diameter, 
metal bipolar stimulating electrode connected to an isolation unit, 
and programmable pulse generator (Master-8, AMPI). Stimulation 
parameters were: pulse duration - 0.2 ms; intensity - 2~4× the 
threshold current for evoking an optical response; train duration 
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- 1.0 s; frequency - 20 Hz; intertrain interval - 5 min. Each image 
included all of the hippocampus on the same side. 30~60 images 
were obtained in association with each repetitive stimulus (a “trial”). 
The 1st and 2nd images (“reference” images) in each trial were 
obtained at 1,000 ms and at 500 ms, respectively, prior to stimulus 
onset; 2 “poststimulus onset” images were acquired during delivery 
of the repetitive stimulus, and the remaining 26 images after 
stimulus termination (image acquisition rate=2/s). Trial duration 
was 9s. An average (across-frame) difference image was generated 
from the optical response to each repetitive Shaffer collateral 
stimulus by (1) subtracting the reference image obtained at 500 ms 
before stimulus onset from each image obtained in the same trial 
between 2.0~7.5 s after stimulus onset (images 6~25; total of 20), 
and (2) at each pixel location by dividing the sum of the differences 
between the post-stimulus and reference images (same-trial) by 
the number of frames. An intensity value was calculated for each 
pixel in a difference image using the formula ∑(Tij-Ti,ref)/Ti,ref, where 
Tij is the intensity of the i
th pixel in the j th image, and Ti,ref  is the 
intensity of the i th pixel in the reference image. Mean intensity (ΔT/
T) of the IOS was determined by computing the average intensity 
of all pixels within the responding region of the striatum radiaum 
on the IOS of bath-applied drug (either 5 mM NaF or μM U0126, 
or 50 μM Acetazolamide, or 50 μM Niflumic acid, or 50 μM NPPB, 
or 10 μM Bumetanide and 10 μM Furosemide in combination) 
was expressed as a percentage of the mean intensity of the response 
observed prior to treatment: i.e., ΔT/Ttreatment/ΔT/Tcontrol×100=%. 
Drugs
All chemicals for ACSF were purchased from Sigma Aldrich. 
U0126 (MAPK inhibitor), and Bumetanide / Furosemide (potent 
NKCC1 inhibitor) were purchased from Sigma. , NPPB, Anion 
channel blockers, and and DCPIB, VRAC blocker, were obtained 
form Tocris. 
ResUlTs
The neuronal activity-dependent transient volume change along 
with baseline volume change was detected and visualized as an 
IOS upon intense electrical stimulation of Schaffer collateral 
fibers for 1 s at 20 Hz (Fig. 1A) with a rise (4~6 s) and decay 
Fig. 1. NaF decreased peak amplitude and baseline of intrinsic optical signal (IOS) in hippocampal slices. (A) Series of pseudo color images at 
different time with electrical stimulation was shown for change of light transmittance. (B) Example of light transmittance change of CA1 SR area and 
measurement of transmittance intensity. (C) Representative example of IOS before and during NaF application. Numbers with red color indicate 
where IOS recorded. Dotted line indicated that shifting of baseline with application of NaF. (D) Time course of IOS for baseline and amplitude during 
application of 5 mM NaF. Baseline, peak, and amplitude of IOS are indicated with black circle (●), and gray circle (●) respectively.
75www.enjournal.orghttp://dx.doi.org/10.5607/en.2016.25.2.72
Fluoride Reduces Hippocampal Volume Via MAPK by Opening VRAC
(70~80 s) in light transmittance through stratum radiatum  of 
CA1 hippocampal slices (Fig. 1B), as previously described [15, 
19]. This stimulation-induced IOS was recorded repetitively 
at every 5 min (Fig. 1C and D). For analysis, we measured the 
baseline change and amplitude that was the maximal difference 
of light transmittance, which reached at 4~5 sec after electrical 
stimulation (Fig. 1B). Using this IOS technique, we tested the effect 
of NaF on volume regulation. We found that upon application of 
5 mM NaF the baseline and amplitude of stimulation-induced 
IOS dropped dramatically and remained decreased even after 
washout with normal ACSF (Baseline; % of ΔT/T, Control, 0.64 
± 0.15; NaF, -15.30±0.93; Washout, -25.34±0.61, n=9) (Peak; % of 
ΔT/T, Control, 6.44±0.16; NaF, -12.34±2.65; Washout, -22.90±2.03, 
n=9) (Amplitude=Peak - Baseline, % of ΔT/T, Control, 5.80±; NaF, 
2.96±1.79; Washout, 2.44±1.32) (Fig. 1C and D). These results 
suggest that fluoride has a potent volume-reducing effect on 
cellular volume in hippocampal slices. 
Because NaF is known as G-protein activator and activated 
MAP kinase [27, 28, 33], we tested whether NaF-induced volume 
reduction is dependent on the activity of  MAP kinase. To 
investigate MAP kinase dependency, we monitored NaF-induced 
light transmittance change from hippocampal slices with MAP 
kinase inhibitor. We found that co-treatment of NaF and 10 μM 
U0126, MAP kinase inhibitor, initially reduced the baseline of 
light transmittance slightly (Fig. 2B and D). However, the baseline 
gradually recovered to the control level (Fig. 2A, middle panel, 
inset 3; % of baseline, 99.56±4.75, n=9), compared to NaF alone 
(Fig. 2A; % of baseline, 76.71±4.71, n=9). More importantly, we 
found that pre-treatment of U0126 completely prevented NaF-
induced volume reduction (Fig. 2C; % of baseline, 98.06±4.75, 
n=3). These results indicate that fluoride shows a potent volume-
reducing effect on brain tissue that is dependent on MAP kinase 
activity.
Next, we investigated the downstream target of NaF-activated 
MAP kinase pathway. We selected candidate targets that are 
likely influenced by MAP kinase and potentially involved in 
volume regulation and pharmacologically tested three candidates: 
aquaporin, anion channels, and NKCC1. We found that although 
all three candidates show some degree of blocking effect, anion 
channel blockers, niflumic acid (NFA), NPPB, and DCPIB have the 
most significant blocking effect on NaF-induced volume reduction 
(Fig. 3A and B; % of ΔT/T, 5 mM NaF, -12.66±1.07, n=9; NaF+10 
μM U0126, 0.60±0.05, n=9; 20 μM Acetazolimide for aquaporin 
blocker, -3.11±0.02, n=9; 100 μM NFA, 200 μM NPPB, and 10 μM 
Fig. 2. MAPK inhibitor blocked decrease of ΔT/T baseline. (A-C) Time course of baseline change by NaF (A) and coapplication with U0126 (B, C) 
was shown. Difference of light transmittance was normalized by drug-free condition - the baseline before NaF treatment. (D) Example of IOS image 
at different time followed by NaF and U0126 coapplication was shown. Red traces in images indicated the change of light intensity evoked by 20 Hz 
stimulation measured from the area of hippocampus (indicated with dotted line box). Scale bar is 3 s and 1%. 
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DCPIB for anion channel blockers, -1.03±0.14, n=9, -1.37±0.03, 
n=7, and -0.23±0.56, n=4 respectively; 25 μM Bumetanide and 
3 mM Furosemide for NKCC1 blockers, -6.67±0.12, n=11 and 
-4.98±β0.21, n=6 respectively). Among the anion channel blockers, 
DCPIB, a known selective blocker for VRAC [34, 35], showed 
most inhibitory effect of NaF-induced volume reduction. This 
result indicates that NaF-induced volume reduction is mostly 
mediated by opening of VRAC.
DIsCUssION
The present report describes NaF, a well-known G-protein 
activator and protein phosphatase inhibitor, leads to a significant 
activation of MAP kinase, followed by a substantial volume 
reduction in hippocampal slices. Our study demonstrates that 
acute application of sub-chronic dose of NaF causes a critical effect 
on volume regulation and leads to suppression of neural activity. 
We found that NaF-induced reduction of hippocampal volume 
as well as neural activity was critically dependent on MAP kinase 
activity in hippocampal slices. 
Regulation of cell volume is an important aspect of cellular 
homeostasis during neural activity. In the brain, concentration 
gradient of osmolytes and ions in between cell membrane is 
known to change following neural activity [16, 36, 37]. As ions and 
water move from plasma through ion channels, transporters, and 
water channels, the brain cell volume must be tightly controlled 
to avoid significant changes in cell size during subsequent neural 
activity. Thus it is expected that cells have fairly well developed 
regulatory cell volume mechanisms in the brain. In current study, 
anion channel blockers have the most inhibitory effect on NaF-
induced volume reduction (Fig. 3), which strongly suggests that 
flouride ion induced opening of anion channels to enhance efflux 
of Cl- and osmolytes. It has been suggested that astrocytes are the 
major cell types in the brain to maintain homeostasis of cellular 
environment. Although we have not provided detailed analysis of 
cell types, NaF-induced reduction of light transmittance following 
the shrinkage of tissue volume is probably mediated by an efflux 
of Cl- and osmolytes from astrocytes. Future study is needed to 
address this important question.
Our study provides an explanation for the negative aspect of 
NaF in that an exposure of the chemical to hippocampal slices 
induces a dramatic volume reduction. It might be related with an 
activity of VRAC through MAP kinase signaling pathway. These 
findings imply that NaF-induced toxicity might be related with 
volume regulatory system in the brain, which could alter normal 
brain function. To extend our knowledge of the effect of NaF in 
the brain, the identification of specific cell type and the molecular 
identity of anion channel for the regulation of cellular volume 
need to be investigated in the future study.
In summary, despite its broad industrial and health applications, 
fluoride’s effect in the brain has remained unclear. In the present 
study, we pharmacologically addressed the molecular mechanism 
of NaF-induced volume reduction. We propose that NaF can 
be a useful tool to activate VRAC via activation of MAP kinase 
pathway. We also raise an important public concern that chronic 
use of fluoride can exert toxic effect on brain function through the 
Fig. 3. Reduction of baseline for IOS induced by NaF shows anion 
channel(s) dependency. (A-C) Exemplary time course of the effect of 
NPPB and DCPIB on NaF-induced volume reduction was shown. (D) 
Summary bar graph of reduction of light transmittance for various 
antagonists compared with NaF effect.
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negative influence on brain volume dynamics.
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